Ex vivo expansion of the highly cytotoxic human natural killer-92 cell-line under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy

By Tam Yk   Martinson Ja   Doligosa K   Klingemann H-g  

Cytotherapy, Vol. 5, Iss. 2, 2003-01 ,pp. : 259-272

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Ex vivo expansion of natural killer cells for clinical applications

By Klingemann H-g   Martinson J  

Cytotherapy, Vol. 6, Iss. 1, 2004-01 ,pp. : 15-22

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Ex vivo expansion of natural killer cells: a question of function

By Sutlu Tolga   Alici Evren  

Cytotherapy, Vol. 13, Iss. 6, 2011-07 ,pp. : 767-768

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications

By Lapteva Natalia   Durett April G.   Sun Jiali   Rollins Lisa A.   Huye Leslie L.   Fang Jian   Dandekar Varada   Mei Zhuyong   Jackson Kimberley   Vera Juan   Ando Jun   Ngo Minhtran C.   Coustan-Smith Elaine   Campana Dario   Szmania Susann   Garg Tarun   Moreno-Bost Amberly   Vanrhee Frits   Gee Adrian P.   Rooney Cliona M.  

Cytotherapy, Vol. 14, Iss. 9, 2012-10 ,pp. : 1131-1143

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Feasibility and safety of adoptive immunotherapy with ex vivo-generated autologous, cytotoxic T lymphocytes in patients with solid tumor

By Montagna Daniela   Turin Ilaria   Schiavo Roberta   Montini Enrica   Zaffaroni Nadia   Villa Raffaella   Secondino Simona   Schiavetto Ilaria   Caliogna Laura   Locatelli Franco   Libri Virginia   Pession Andrea   Tonelli Roberto   Maccario Rita   Siena Salvatore   Pedrazzoli Paolo  

Cytotherapy, Vol. 14, Iss. 1, 2012-01 ,pp. : 80-90

Ashgate Publishing Ltd

Access to resources Recommend Favorite